These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21067720)

  • 1. Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.
    Gao MZ; Zhao XM; Sun ZG; Hong Y; Zhao LW; Zhang HQ
    Fertil Steril; 2011 Feb; 95(2):673-8. PubMed ID: 21067720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EG-VEGF concentrations may predict OHSS.
    Ajonuma LC; Ajuonuma MU; Ajuonuma BC; Ogbedeagu VM; Ajuonuma JU; Chukwu CL
    Fertil Steril; 2011 Jun; 95(7):e37; author reply e38. PubMed ID: 21507397
    [No Abstract]   [Full Text] [Related]  

  • 3. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome?
    Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V
    J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of soluble vascular endothelial growth factor receptor 1/sFlt1 and low levels of vascular endothelial growth factor in follicular fluid on the day of oocyte retrieval correlate with ovarian hyperstimulation syndrom regardless of the stimulation protocol.
    Jakimiuk AJ; Nowicka MA; Zagozda M; Koziol K; Lewandowski P; Issat T
    J Physiol Pharmacol; 2017 Jun; 68(3):477-484. PubMed ID: 28820403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Function of vascular endothelial growth factor in ovarian hyperstimulation syndrome].
    Liang W; Chen S; Xing F
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):651-3. PubMed ID: 11930687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.
    Artini PG; Monti M; Matteucci C; Valentino V; Cristello F; Genazzani AR
    Gynecol Endocrinol; 2006 Aug; 22(8):465-70. PubMed ID: 17012110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q; Yang G; Yang C; Zhan B; Yang R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?
    Ocal P; Aydin S; Cepni I; Idil S; Idil M; Uzun H; Benian A
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):194-9. PubMed ID: 15262355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
    Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
    Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
    Zhou C; Yu C; Zhuang G
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome.
    Cerrillo M; Pacheco A; Rodríguez S; Gómez R; Delgado F; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2011 Jun; 95(8):2517-9. PubMed ID: 21269615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of EG-VEGF, VEGF and TGF-β1 on pregnancy outcome in patients undergoing IVF-ET treatment.
    Gao MZ; Zhao XM; Lin Y; Sun ZG; Zhang HQ
    J Assist Reprod Genet; 2012 Oct; 29(10):1091-6. PubMed ID: 22847371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization.
    Dorn C; Reinsberg J; Kupka M; van der Ven H; Schild RL
    Arch Gynecol Obstet; 2003 Aug; 268(3):187-93. PubMed ID: 12942249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of Ovarian Hyperstimulation Syndrome in IVF patients.
    Moos J; Rezabek K; Filova V; Moosova M; Pavelkova J; Peknicova J
    Reprod Biol Endocrinol; 2009 Aug; 7():86. PubMed ID: 19703287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome.
    Gutman G; Soussan-Gutman L; Malcov M; Lessing JB; Amit A; Azem F
    Am J Reprod Immunol; 2004 May; 51(5):381-4. PubMed ID: 15212675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of stromal cell-derived factor-1 and vascular endothelial growth factor in relation to the diameter of human follicles.
    Nishigaki A; Okada H; Okamoto R; Sugiyama S; Miyazaki K; Yasuda K; Kanzaki H
    Fertil Steril; 2011 Feb; 95(2):742-6. PubMed ID: 21071025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome.
    Chen CD; Chen HF; Lu HF; Chen SU; Ho HN; Yang YS
    Hum Reprod; 2000 May; 15(5):1037-42. PubMed ID: 10783347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of leptin, interleukin-1beta, tumor necrosis factor-alpha and vascular endothelial growth factor in serum and follicular fluids of women undergoing controlled ovarian hyperstimulation as prognostic markers of ICSI outcome.
    Nikolettos N; Asimakopoulos B; Nicolettos N; Efthimiadou A; Mourvati E; Demirel C
    In Vivo; 2004; 18(5):667-73. PubMed ID: 15523910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.